Vascular Diseases – Peripheral/Aorta

  • Craig R. Narins
  • Jason D. Pacos
  • Theodore I. Hirokawa


Peripheral arterial disease (PAD) is a common yet vastly underdiagnosed condition that is associated with substantial morbidity and mortality. Because atherosclerosis is a systemic disease, the presence of PAD, whether symptomatic or not, is associated with a two- to fourfold increase in the risk of myocardial infarction, stroke and cardiovascular death [1–3]. More timely diagnosis of PAD in the primary care setting has the potential not only to improve quality of life by helping to alleviate the lifestyle-impairing symptoms often associated with the disease, but also to identify individuals at high risk for cardiac and cerebrovascular events providing the opportunity to initiate effective life-saving therapies at an earlier stage [4].


Abdominal Aortic Aneurysm Peripheral Arterial Disease Renal Artery Stenosis Critical Limb Ischemia Intermittent Claudication 


  1. 1.
    Ankle Brachial Index C. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.CrossRefGoogle Scholar
  2. 2.
    Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114(7):688–99.PubMedCrossRefGoogle Scholar
  3. 3.
    Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120(21):2053–61.PubMedCrossRefGoogle Scholar
  4. 4.
    Perlstein TS, Creager MA, Perlstein TS, Creager MA. The ankle-brachial index as a biomarker of cardiovascular risk: it’s not just about the legs. Circulation. 2009;120(21):2033–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24.PubMedCrossRefGoogle Scholar
  6. 6.
    White C. Intermittent claudication. N Engl J Med. 2007;356(12):1241–50.PubMedCrossRefGoogle Scholar
  7. 7.
    McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–606.PubMedCrossRefGoogle Scholar
  8. 8.
    Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Circulation. 1995;92(3):614–21.PubMedGoogle Scholar
  9. 9.
    Varu VN, Hogg ME, Kibbe MR. Critical limb ischemia. J Vasc Surg. 2010;51(1):230–41.PubMedCrossRefGoogle Scholar
  10. 10.
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.PubMedCrossRefGoogle Scholar
  11. 11.
    McGee SR, Boyko EJ. Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med. 1998;158(12):1357–64.PubMedCrossRefGoogle Scholar
  12. 12.
    Cheer K, Shearman C, Jude EB. Managing complications of the diabetic foot. BMJ. 2009;339:1304–7.Google Scholar
  13. 13.
    Grenon SM, Gagnon J, Hsiang Y, Grenon SM, Gagnon J, Hsiang Y. Video in clinical medicine. Ankle-brachial index for assessment of peripheral arterial disease. N Engl J Med. 2009;361(19):e40.PubMedCrossRefGoogle Scholar
  14. 14.
    Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med. 2001;18(7):528–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Stein R, Hriljac I, Halperin JL, Gustavson SM, Teodorescu V, Olin JW. Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease. Vasc Med. 2006;11(1):29–33.PubMedCrossRefGoogle Scholar
  16. 16.
    Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improve­ment Initiative (PVD-QI2). Circulation. 2002;106(15):1909–12.PubMedCrossRefGoogle Scholar
  17. 17.
    Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease. Circulation. 2006;113(11):e463–654.PubMedCrossRefGoogle Scholar
  18. 18.
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.PubMedCrossRefGoogle Scholar
  19. 19.
    Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003;107(5):753–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Heart Protection Study Collaborative G. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45(4):645–54.CrossRefGoogle Scholar
  21. 21.
    Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009;301(18):1909–19.PubMedCrossRefGoogle Scholar
  22. 22.
    Clagett GP, Sobel M, Jackson MR, Lip GY, Tangelder M, Verhaeghe R. Antithrombotic therapy in peripheral arterial occlusive disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):609S–26.PubMedCrossRefGoogle Scholar
  23. 23.
    McDermott MM, Criqui MH. Aspirin and secondary prevention in peripheral artery disease: a perspective for the early 21st century. JAMA. 2009;301(18):1927–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25(1):17–24.PubMedCrossRefGoogle Scholar
  25. 25.
    Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145–53.PubMedCrossRefGoogle Scholar
  26. 26.
    Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med. 1991;151(9):1769–76.PubMedCrossRefGoogle Scholar
  27. 27.
    Narins CR, Zareba W, Moss AJ, Marder VJ, Ridker PM, Krone RJ, et al. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med. 2004;164(4):440–6.PubMedCrossRefGoogle Scholar
  28. 28.
    McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301(2):165–74.PubMedCrossRefGoogle Scholar
  29. 29.
    Chi YW, Lavie CJ, Milani RV, White CJ. Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag. 2008;4(6):1197–203.PubMedGoogle Scholar
  30. 30.
    Mahmud E, Cavendish JJ, Salami A. Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol. 2007;50(6):473–90.PubMedCrossRefGoogle Scholar
  31. 31.
    Dworkin LD, Cooper CJ. Renal-artery stenosis. N Engl J Med. 2009;361(20):1972–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Olin JW, Pierce M. Contemporary management of fibromuscular dysplasia. Curr Opin Cardiol. 2008;23(6):527–36.PubMedCrossRefGoogle Scholar
  33. 33.
    ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–62.CrossRefGoogle Scholar
  34. 34.
    George JC, White CJ. Renal artery stenting: lessons from ASTRAL (Angioplasty and Stenting for Renal Artery Lesions). JACC Cardiovasc Interv. 2010;3(7):786–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Sixt S, Rastan A, Schwarzwalder U, Burgelin K, Noory E, Schwarz T, et al. Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction. Catheter Cardiovasc Interv. 2009;73(3):395–403.PubMedCrossRefGoogle Scholar
  36. 36.
    Metcalfe D, Holt PE, Thompson M. The management of abdominal aortic aneurysms. BMJ. 2011;342:644–9.CrossRefGoogle Scholar
  37. 37.
    Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, et al. The care of patients with an abdominal aortic aneurysm: the society for vascular surgery practice guidelines. J Vasc Surg. 2009;50(4 Suppl):S2–49.PubMedCrossRefGoogle Scholar
  38. 38.
    Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey Jr DE, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice G. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease. Circulation. 2010;121(13):e266–369.PubMedCrossRefGoogle Scholar
  39. 39.
    Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M, et al. Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg. 2011;41 Suppl 1:S1–58.PubMedCrossRefGoogle Scholar
  40. 40.
    Greenhalgh RM, Powell JT. Endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2008;358(5):494–501.PubMedCrossRefGoogle Scholar
  41. 41.
    Golledge J, Eagle KA. Acute aortic dissection. Lancet. 2008;372(9632):55–66.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  • Craig R. Narins
    • 1
  • Jason D. Pacos
    • 2
  • Theodore I. Hirokawa
    • 3
  1. 1.Department of Cardiology and Vascular SurgeryUniversity of Rochester School of MedicineRochesterUSA
  2. 2.Department of CardiologyUniversity of Rochester Medical CenterRochesterUSA
  3. 3.Department of SurgeryHighland HospitalRochesterUSA

Personalised recommendations